SierraSil Joint Formula 14 as an Ergogenic Aid to Performance in Athletes
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to examine whether supplementation with SierraSil can improve anaerobic power and reduce muscle fatigue in a group of well-trained athletes.
A secondary purpose is to examine the effect of SierraSil on the severity of delayed onset muscle soreness.
Full description
This is a double blind, crossover, pilot study that will examine the effect of SierraSil supplementation on the determinants of human performance. Anaerobic capacity, muscle fatigue, the severity of delayed onset muscle soreness (DOMS) and markers of inflammation will be measured before and after 3 weeks of supplementation with SierraSil or placebo. There will be a 3 week washout period prior to the crossover to ensure SierraSil supplementation has no residual effect.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- no contraindications to strenuous exercise
Exclusion criteria
- muscle or joint injury
- taking any form of anti-inflammatory or pain medication
- females due to the variability that might be introduced due to the phases of the menstrual cycle
Trial design
Primary purpose
Allocation
Interventional model
Masking
10 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal